Skip to main content
. 2020 Jun 5;15:138. doi: 10.1186/s13023-020-01422-8

Table 2.

Summary of the variants analysis

GENE mutation ENG, n (%) ACVRL1, n (%)
Patients, n 36 77
Sequencing method, n (%)
 Sanger 20 (55.5) 45 (58.4)
 NGS 12 (33.3) 26 (33.8)
 Others 4 (11.1) 6 (7.8)
Variant type, n (%)
 Nonsense 10 (27.7) 39 (50.6)
 Frameshift 13 (36.1) 20 (25.9)
 Splice-site 4 (11.1) 3 (3.9)
 Missense 9 (25) 15 (19.4)

NGS Next-generation sequencing